Jump ahead
Mast Cell Activation Syndrome (MCAS) is an immunological disorder where mast cells, a type of white blood cell, release excessive chemical mediators like histamine, triggering a cascade of symptoms that can affect the skin, gastrointestinal tract, heart, lungs, and nervous system. Estimated to affect up to 17% of the population. MCAS often goes undiagnosed due to its diverse, fluctuating symptoms and lack of standardized diagnostic criteria. From chronic hives to debilitating fatigue, patients face significant challenges in daily life. This article explores MCAS’s complexities, including its symptoms, diagnostic hurdles, and treatment options, offering insights for patients and caregivers seeking to navigate this underrecognized condition.
What Is Mast Cell Activation Syndrome?
Mast cells, found in tissues throughout the body, are critical to immune responses, releasing mediators like histamine, leukotrienes, and tryptase to fight infections and promote healing. Unlike mastocytosis, a condition where the body makes too many mast cells, Mast Cell Activation Syndrome (MCAS) is when mast cells become hyperactive, releasing mediators excessively or inappropriately, often without clear triggers.
MCAS is classified into three subtypes:
- Primary: when mast cells have a genetic mutation, such as the KIT D816V mutation. This mutation causes mast cells to be abnormal – they may grow more than usual or become overly sensitive.
- Secondary: When normal mast cells become overly active because of external triggers. These triggers can include allergies (like reactions to foods, medications, or insect stings) or other conditions that stimulate mast cells to become overactive.
- Idiopathic: no identifiable cause.
How common is MCAS? Estimates vary widely. Some call it rare, others suggest up to 1 in 6 people might be affected, hinting it’s far more widespread than once believed. Symptoms vary from person to person, creating a puzzle for doctors.
This confusion leads to frequent misdiagnosis or years-long delays, leaving patients searching for answers, but understanding is growing, and better recognition is on the horizon.
MCAS Symptoms and Triggers
MCAS symptoms are multisystemic and unpredictable, including:
- Gastrointestinal distress (nausea, diarrhea, abdominal pain)
- Skin issues (hives, flushing, itching)
- Cardiovascular problems (rapid heart rate, low blood pressure)
- Respiratory difficulties (wheezing, shortness of breath)
- Neurological complaints (brain fog, anxiety, depression)
Severe cases may lead to anaphylaxis, a life-threatening allergic reaction.
MCAS triggers are highly individualized and can include:
- Environmental allergens: pollen, mold, smoke, fragrances
- Food intolerances or allergies: high-histamine or high-FODMAP foods and alcohol
- Physical stimuli: temperature changes, exercise
- Medications: NSAIDs, opioids, antibiotics
- Infections: viral, bacterial, fungal
- Emotional or physical stress
- Hormonal fluctuations: menstruation, menopause, pregnancy
- Venoms: insect bites/stings
- Chemical exposures: heavy metals, pesticides, solvents, personal care products
- Weather changes
Co-existing conditions (comorbidities) like postural orthostatic tachycardia syndrome (POTS), Ehlers-Danlos Syndrome (EDS), and small intestinal bacterial overgrowth (SIBO) are common, suggesting interconnected mechanisms. Symptoms often wax and wane, making it hard to pinpoint triggers, which can evolve over time, further complicating diagnosis and management.
Diagnosis Challenges
There’s no standard test. Doctors look for: symptoms in two or more body systems, high levels of mast cell chemicals during symptoms, and improvement with treatments like antihistamines. A main blood test checks serum tryptase soon after symptoms start, but normal results don’t rule out MCAS diagnosis. A bone marrow biopsy can confirm some cases but is rarely done. Other conditions with similar symptoms must be ruled out.
Misdiagnosis is common. Symptoms mimic other conditions, and limited physician awareness adds to delays, leaving patients struggling for answers. Many report frustration with misdiagnoses or dismissive healthcare providers, with some enduring symptoms for decades. Women, who make up over 80% of diagnosed cases, often face additional challenges, as symptoms may be mistaken for premenstrual syndrome or psychological issues.
Patients emphasize the importance of self-advocacy, tracking symptoms, and building a care team familiar with MCAS.
Treatment and Management
Treatments aim to stabilize mast cells, block mediators, and prevent inappropriate mast cell activation and histamine release. Managing histamine levels through diet, supplements, lifestyle, and medications can reduce the frequency and severity of MCAS symptoms.
Medications
Antihistamines (H1 and H2 blockers) block histamine receptors and provide symptom relief, but should only be used short-term due to long-term risks. Mast cell stabilizers and targeted biologics may also be used to control mast cell activation. In difficult cases, immunosuppressants may also be used. For anaphylaxis, EpiPens are critical.
Warning: First-generation H1 blockers like diphenhydramine (Benadryl) increase dementia risk by blocking acetylcholine, a neurotransmitter essential for memory and cognition. Second-generation antihistamines such as cetirizine (Zyrtec) and loratadine (Claritin) have fewer anticholinergic effects but may still raise dementia risk, especially with long-term, high cumulative doses.
Supplements and Nutrients
Certain supplements, such as vitamin C, vitamin B6, quercetin, omega-3 fatty acids, and probiotics that favor histamine-degrading bacteria, may support histamine metabolism and immune regulation.
Dietary Changes
Such as low-histamine or low-FODMAP diets, adjusting your diet can reduce symptoms.
Lifestyle and Stress Management
Stress can worsen histamine-related symptoms. Techniques like meditation, yoga, breathing exercises and good sleep not only support your body’s histamine balance but also reduce flare-ups.
Summary
Mast Cell Activation Syndrome is a complex immunological disorder where overactive mast cells trigger multisystemic symptoms, from hives to anaphylaxis. MCAS is often underdiagnosed due to its variable presentation and diagnostic challenges. Treatments like antihistamines, mast cell stabilizers, and trigger avoidance can help, but management is individualized and can require specialist input. Emerging research highlights genetic and environmental factors, as well as links to conditions like POTS and EDS. While living with MCAS is challenging, patient advocacy and tailored care can improve outcomes. Increased awareness and research are critical to better understanding and addressing this condition.
Living with Mast Cell Activation Syndrome (MCAS) can feel overwhelming; this complex immune condition causes unpredictable symptoms. Explore tools that put you in control, backed by science and community support. Learn more
Sources
https://www.researchgate.net/publication/348912052_Mast_Cell
https://pmc.ncbi.nlm.nih.gov/articles/PMC7731385/
https://www.jacionline.org/article/S0091-6749(24)00569-4/abstract
https://www.aaaai.org/conditions-treatments/related-conditions/mcas
https://pmc.ncbi.nlm.nih.gov/articles/PMC6049091
https://pubmed.ncbi.nlm.nih.gov/32328892
https://www.degruyterbrill.com/document/doi/10.1515/dx-2020-0005/html
